Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03660605 · ClinicalTrials.gov registry record · NA

Priming Through Timing. Using Opposing Strategies to Enhance Motor Learning for Individuals With Parkinson's Disease

A NA study of Parkinson Disease, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
4
Enrollment target
1
Study location

NCT03660605 is a NA study of Parkinson Disease that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 4 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03660605, a NA study of Parkinson Disease, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine how using auditory cues of a metronome at various frequencies impacts the gait mechanics and balance in people with Parkinson's disease when walking over ground and on a treadmill. We will enroll 10 participants with a diagnosis of Parkinson's disease (Stages 2 or 3). All participants will complete 18 training sessions over 6 weeks and participate in pre- and post-testing of gait and balance.

Conditions Studied

Interventions

  • OTHER Rhythmic Auditory Stimulation

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2018-09-15
Est. Completion 2019-09-15
Phase NA

What the Registry Record Tells You About NCT03660605

The ClinicalTrials.gov registry entry for NCT03660605 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Rhythmic Auditory Stimulation is the first listed.

NCT03660605 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03660605 about?

NCT03660605 is a clinical study titled "Priming Through Timing. Using Opposing Strategies to Enhance Motor Learning for Individuals With Parkinson's Disease". The purpose of this study is to determine how using auditory cues of a metronome at various frequencies impacts the gait mechanics and balance in people with Parkinson's disease when walking over ground and on a treadmill. We will enroll 10 participants with a diagnosis of Parkinson's disease (Stage...

What is the current status of trial NCT03660605?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2018-09-15. Estimated completion is 2019-09-15.

What conditions does trial NCT03660605 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT03660605?

The interventions under investigation include: Rhythmic Auditory Stimulation (OTHER).

Who is sponsoring clinical trial NCT03660605?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03660605 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.